Intra-day tips from Geojit BNP Paribas; Buy YES Bank, Sun Pharma

Here are a few intra-day trading strategies from Geojit BNP Paribas for trade today:

YES BANK (Rs 672.95)

Support at Rs 668 below Rs 665. Resistance is at Rs 679.50 above Rs 686.55. (Buy for intraday with a stoploss below Rs 665)

[STOCHASTICS BUY + VOLUME JUMP + OVERSOLD]

SUN PHARMACEUTICALS INDUSTRIES (Rs 788.15)

Support at Rs 780 below Rs 777. Resistance is at Rs 797 above Rs 803. (Buy for intraday with a stoploss below Rs 777)

[STOCHASTICS BUY + ABV PREVIOUS CLOSE + ABV 50 DMA]

NILKAMAL (Rs 1,547.45)

Support at Rs 1,540 below 1,532. Resistance is at Rs 1,568 above Rs 1,572. (Buy for intraday with a stoploss below Rs 1,532)
 
[MACD & STOCHASTICS BUY + ABV MOVING AVERAGES + VOLUME JUMP + NEW HIGH]

LAMBODHARA TEXTILES (Rs 213.45)

Support at Rs 209 below Rs 207.05. Resistance is at Rs 216 above Rs 219.95 (Buy for intraday with a stoploss below Rs 207.05)

[STOCHASTICS BUY + ABV PREVIOUS CLOSE + VOLUME JUMP]

MUKTA ARTS (Rs 79.45)

Support at Rs 78.10 below Rs 76.50. Resistance is at Rs 81.50 above Rs 84 (Buy for intraday with a stoploss below Rs 76.50)

[MACD & STOCHASTICS BUY + ABV MOVING AVERAGES + VOLUME JUMP + NEW HIGH]

Disclaimer: This report has been prepared by Geojit BNP Paribas Financial Services Limited (GBNPP), here in after referred to as GBNPP. GBNPP, a publicly listed company, is engaged in services of retail broking, credit, portfolio management and marketing investment products including mutual funds, life and general insurance and properties. Each recipient of this report should make such investigation as it deems necessary to arrive at an independent evaluation of an investment in the securities of companies referred to in this report (including the merits and risks involved). This document is not for public distribution and has been furnished to you solely for your information and must not be reproduced or redistributed to any other person. Persons into whose possession this document may come are required to observe these restrictions. Opinion expressed herein is our current opinion as of the date appearing on this report only. While we endeavor to update on a reasonable basis the information discussed in this material, there may be regulatory, compliance, or other reasons that prevent us from doing so. Prospective investors and others are cautioned that any forward-looking statements are not predictions and may be subject to change without notice.